Skip to main content
Aprogen, Inc logo

Aprogen, Inc — Investor Relations & Filings

Ticker · 007460 ISIN · KR7007460009 KO Manufacturing
Filings indexed 735 across all filing types
Latest filing 2024-01-10 Regulatory Filings
Country KR South Korea
Listing KO 007460

Aprogen, Inc. is a biopharmaceutical company focused on the research, development, and manufacturing of biologic medicines. The company's core activities are centered on developing both biosimilars and novel drugs, including new protein therapeutics and bispecific antibodies. Its product development is based on proprietary technologies in antibody engineering and recombinant protein engineering.

Recent filings

Filing Released Lang Actions
투자판단관련주요경영사항(특허권 취득)
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) system, specifically a 'Major Management Matter' (투자판단 관련 주요경영사항) disclosure regarding the acquisition of a patent. Since this is a specific regulatory announcement of a corporate event (patent acquisition) that does not fall into the specialized categories like M&A, dividends, or financial reports, it is classified as a general Regulatory Filing (RNS).
2024-01-10 Korean
[기재정정]주요사항보고서(전환사채권발행결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Report' (주요사항보고서) filed with the Korean financial authorities (Financial Services Commission/Korea Exchange) regarding a correction (정정신고) to a previously filed 'Decision to Issue Convertible Bonds' (전환사채권 발행결정). It details changes to collateral terms and updates on outstanding convertible bonds. Since it is a formal regulatory filing detailing capital structure changes and financing updates, it falls under the 'Capital/Financing Update' category.
2024-01-09 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is titled '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is a standard regulatory filing in South Korea (often referred to as a 5% rule filing). It details the shareholding status, changes in ownership, and contractual relationships (such as collateral agreements) of major shareholders and their special related parties. This falls under the category of Major Shareholding Notification.
2024-01-05 Korean
투자판단관련주요경영사항(특허권 취득)
Regulatory Filings Classification · 100% confidence The document is a formal regulatory filing from the Korea Exchange (KRX) system, titled 'Investment Judgment Related Major Management Matters' (투자판단 관련 주요경영사항). It specifically announces the acquisition of a patent in Mexico. Since this is a standard corporate disclosure regarding a material business event (patent acquisition) that does not fall into specific categories like financial reports, M&A, or dividends, it is classified as a general regulatory filing.
2024-01-05 Korean
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from the Korean DART system regarding a 'Correction Report' (정정신고) for a 'Single Sale/Supply Contract' (단일판매ㆍ공급계약체결). It details an amendment to the contract end date. Since this is a specific regulatory disclosure regarding a contract amendment that does not fit into categories like M&A, dividends, or financial reports, it falls under the general regulatory filing category.
2023-12-28 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the share ownership, special relationships, and changes in holdings of major shareholders (e.g., G-BASE, Aprogen). This type of document is specifically used to notify the market and regulators of significant ownership stakes and is classified as a Major Shareholding Notification.
2023-12-28 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.